Skip to Content
  • 1.8
    Impact Factor
  • 2.6
    CiteScore
  • 20 days
    Submission to First Decision
  • 5 days
    Acceptance to Publication

Biophysica

Biophysica is an international, peer-reviewed, open access journal on applying the methods of physics, chemistry, and math to study biological systems, published bimonthly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within  ESCI (Web of Science), Scopus, EBSCO, and other databases.
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 19.1 days after submission; acceptance to publication is undertaken in 4.7 days (median values for papers published in this journal in the first half of 2026).
  • Recognition of Reviewers: Reviewers whose reports are timely and of high quality receive an APC discount voucher for a future publication in an MDPI journal. Become a reviewer.
  • Biophysica is a companion journal of IJMS.

Get Alerted

Add your email address to receive forthcoming issues of this journal.

All Articles (337)

  • Review
  • Open Access

Cancer is a complex and heterogeneous disease characterized by dynamic genetic, metabolic, and microenvironmental alterations. In addition to established classical biological mechanisms, quantum-scale processes such as proton tunneling, electron transfer, and spin-dependent reactions have been proposed to contribute to selected molecular events relevant to cancer biology. This review examines the current evidence supporting these mechanisms and discusses their possible implications for mutagenesis, mitochondrial metabolism, and reactive oxygen species regulation. We also review quantum dot-based approaches for tumor imaging, biosensing, targeted drug delivery, and photodynamic therapy, together with emerging applications of quantum computing and quantum machine learning in molecular simulation, cancer classification, and treatment optimization. Although these approaches have generated substantial experimental and theoretical interest, most remain at the preclinical, proof-of-concept, or computational stage, and their clinical relevance has not yet been firmly established. Important limitations include biological decoherence, uncertainty regarding the magnitude and functional significance of quantum effects in complex cellular environments, toxicity and biodistribution concerns associated with some quantum materials, limitations of current quantum hardware, and the need for rigorous external and clinical validation. Future progress will depend on multidisciplinary research that clearly distinguishes established molecular-scale quantum phenomena from speculative interpretations and evaluates whether quantum-informed technologies provide measurable advantages over conventional approaches. Overall, quantum science may offer complementary perspectives and technological tools for oncology, but its clinical impact remains to be determined.

Biophysica

12 October 2026

Quantum dot-based applications in oncology. Schematic overview of the major diagnostic and therapeutic applications of quantum dots (QDs) in cancer. QDs can support tumor imaging through their high photostability, tunable fluorescence, and multiplexing capabilities; enable ultra-sensitive biosensing of cancer-related biomarkers such as miRNAs, circulating tumor DNA (ctDNA), and proteins; and serve as multifunctional nanocarriers for targeted and controlled drug delivery. In photodynamic therapy, photoexcited QDs may participate in energy-transfer processes, including Förster resonance energy transfer (FRET), leading to the generation of reactive oxygen species (ROS) and tumor-cell cytotoxicity. The integration of diagnostic imaging and therapeutic functions within a single QD-based platform forms the basis of nanotheranostic approaches, with potential applications in treatment monitoring and precision oncology. In the PDT schematic, 3O2 denotes ground-state triplet molecular oxygen, 1O2 denotes singlet oxygen, O2•− denotes the superoxide radical, and •OH denotes the hydroxyl radical. FRET refers to Förster resonance energy transfer, and ROS refers to reactive oxygen species.
  • Article
  • Open Access

Hexokinase-I anchors to voltage-dependent anion channel 1 (VDAC1) at a membrane-buried glutamate, E73, and disrupting this contact is an established anticancer objective. The site-directed docking of natural product libraries into such hotspots routinely identifies disruptors, yet these candidates are rarely tested for either site specificity or ligand specificity. We screened a verified 43-compound library from Camptotheca acuminata against the VDAC1 E73 groove and then applied five orthogonal controls, calibrated against an empirical uncertainty budget. The conventional workflow was persuasive; ursolic acid ranked first at −7.25 kcal/mol, redocked reproducibly, remained associated with the groove through 100 ns of POPC-embedded dynamics, and returned −42.7 kcal/mol by Molecular Mechanics/Generalized Born Surface Area (MM-GBSA). Replicate calculations then showed that score uncertainty was dominated not by stochastic search, which contributes a standard deviation of 0.007 kcal/mol, but by the arbitrary definition of the site, 0.379 kcal/mol, and by receptor conformation, 0.550 kcal/mol. Against this scale, the controls rule out the candidates. Blind docking identified alternative sites with scores equal to or better than E73. A scan of twenty-four surface sites placed E73 within one box placement standard deviation of several unrelated positions. Neutralizing the E73 carboxylate changed affinity by −0.30 to +0.04 kcal/mol across fifteen compounds. Cholesterol, a membrane lipid, scored within the same uncertainty, and outscored the lead ligand under a second scoring function and in four of six relaxed receptor conformations. Contact occupancies reached 29% for the lead ligand compared to 100% for the reference ligand, NADH. We propose using the controls as a checklist, as illustrated by this case study.

Biophysica

6 October 2026

Ranked affinities of the 43-compound library in the E73-centered box. The top ten are shown in red and the NADH reference as a dashed line. Considered in isolation, this ranking supports ursolic acid as the leading candidate.
  • Article
  • Open Access

Accurate background subtraction is critical in the analysis of X-ray fiber diffraction patterns from striated muscle. Diffuse scattering and low signal-to-noise ratio complicate the separation of signal from background. Existing methods are applied heuristically, without guidance on parameter selection, leading to variability in following analyses. We propose a framework for background removal in muscle fiber diffraction images that evaluates methods and selects optimal parameters. It combines quantitative metrics and validation using synthetic features to guide the optimization. Minimizing the aggregate loss produced visually plausible results in the representative cases examined by the authors; independent blinded validation was not performed. The loss metric and its components allow currently used approaches to be compared within a single reproducible scheme. Individual metrics show trade-offs among approaches, such as preservation of detail or oversubtraction. Additionally, we evaluate parametric fitting of the equatorial streak and isotropic general background, which may be combined with the optimization framework. The framework improves the analysis of fiber diffraction patterns by providing a reproducible quantitative basis for the choice of background subtraction method and its parameters.

Biophysica

29 September 2026

General flow of operations. For each image, following initial preprocessing using standard techniques, relevant parameters and features are estimated, synthetic signal components are generated, and a systematic parameter search is performed.
  • Article
  • Open Access

Bromelain is a widely used as model for papain-like cysteine proteases and shares significant sequence homology with bacterial and viral counterparts, making it a suitable target for computational screening of potential modulators. In this study, we performed molecular docking and protein–ligand interaction profiling for eight synthetic derivatives containing 6-chloroquinolone (compounds 1–4), 1,3,5 triazine (compounds 5–7) or furopyrrole (8) scaffolds. In the quinoline series, the position of the methyl group on the piperidine ring appeared to influence efficacy (4 methyl > unsubstituted > 2 methyl). Molecular docking and PLIP interaction profiling revealed that the highest computed binding affinities (up to –12.4 kcal/mol for 5) did not directly correlate with experimental inhibition, but identified the residues predicted by docking and PLIP to contribute to ligand interactions: Lys18, Phe29, Ile163, Trp180, Tyr185, and Ile186. Ligands 6 and 7 formed H-bonds with catalytic residues His158 and Cys26, respectively. Sequence alignment revealed 42–49% identity between bromelain and bacterial cysteine proteases from Klebsiella pneumoniae and Acinetobacter baumannii, suggesting that bromelain may serve as a tentative model system for the preliminary study of pathogen cysteine proteases, although direct extrapolation would require experimental validation. To experimentally assess these predictions, we conducted a preliminary activity screen using an azocasein proteolytic assay. Compound 1 exhibited a moderate inhibitory effect, whereas compounds 2–8 produced only marginal changes, which lacked statistical significance after correction for multiple comparisons. These findings provide a structural basis for the rational design of new protease inhibitors and identify compound 1 as a preliminary screening hit and a possible starting point for further optimization.

Biophysica

29 September 2026

Structural formulas of bromelain modulators.

Highly Accessed Articles

News & Conferences

Latest Issues

Open for Submission

Journal Sections

XFacebookLinkedIn
Biophysica - ISSN 2673-4125